Context: Plasma soluble leptin receptor (sOb-R) seems protective of gestational and type 2 diabetes in observational studies, but the mechanisms are unknown. sOb-R is formed by ectodomain shedding of membrane-bound leptin receptors (Ob-Rs), but its associations with messenger RNA (mRNA) expression are scarcely explored.
L eptin (16 kDa) was identified in 1994 (1) and is a hormone produced mainly by adipose tissue. Leptin plays a pivotal role in the inhibition of appetite (2, 3) but also in reproduction (4), bone metabolism (5, 6) , and glycemic control (7) . There are four isoforms of the leptin receptor (Ob-R) in humans (8, 9) , which all have identical extracellular domains, but the intracellular domains vary in length. Soluble leptin receptor (sOb-R) is formed by ectodomain shedding of membrane bound Ob-Rs (10) and can be detected in the circulation. Data from a large prospective study of women in the United States showed a strong inverse association between sOb-R and future risk of developing type 2 diabetes (11) . Similarly, we recently found a strong inverse and prospective association between sOb-R levels in early pregnancy and development of gestational diabetes, which share many risk factors and pathophysiological mechanisms with type 2 diabetes (12) , in a population-based cohort of pregnant women (13) . However, the mechanisms responsible for the protective effect of sOb-R on diabetes risk are unclear. Insulin resistance is an important pathophysiological factor in both type 2 (14) and gestational diabetes (12) , but the association between sOb-R and insulin sensitivity as measured by the hyperinsulinemic euglycemic clamp has not yet been reported.
High levels of sOb-R in serum seem to prolong the half-life of leptin and may thereby delay clearance of leptin (15) . Furthermore, high sOb-R levels may reflect high amounts of membrane-bound Ob-R and thereby enhanced leptin signaling. By these mechanisms, sOb-R may be indicative of increased leptin sensitivity. Mutations in the LEPR gene have been associated with sOb-R levels in humans (16) , although the association between sOb-R levels and messenger RNA (mRNA) expression of LEPR, or genes involved in the generation of sOb-R, has not yet been explored.
Our objectives were to explore associations between plasma levels of sOb-R and (1) insulin sensitivity, (2) mRNA pathways in adipose tissue and skeletal muscle, and (3) mRNA of candidate genes for sOb-R generation in adipose tissue and skeletal muscle.
Participants and Methods

Study participants and experimental methods
MyoGlu is a controlled clinical trial (Clinical Trials registration: NCT01803568) in 26 sedentary (,1 exercise session/ wk) men aged 40 to 65 years of Scandinavian origin in 2011 to 2012, Oslo, Norway (17) . We included 13 dysglycemic men [fasting glucose $5.6 mmol/L and/or 2-hour glucose $7.8 mmol/L or with an insulin sensitivity ,4.5 mg/kg/min, body mass index (BMI) 26 to 32 kg/m 2 ] and 13 normoglycemic men (fasting glucose ,5.6 mmol/L and ,7.8 mmol/L without family history of diabetes, BMI 21 to 27 kg/m 2 ). We excluded participants with known hypertension, liver or kidney disease, or chronic inflammatory diseases or those taking any medication expected to affect glucose metabolism (lipid lowering, antihypertensive, acetylsalicylic acid, corticosteroids, etc).
The participants underwent an acute exercise test (45-minute bicycle test at 70% of maximal oxygen consumption volume), followed by adipocyte and muscle biopsies and blood samples.
The participants completed a 12-week period, including a 4-h/wk intensive exercise under careful supervision (two whole-body strength training sessions and two spinning bike interval sessions of 60 minutes duration each). After the 12-week period, the participants underwent another acute exercise test followed by adipocyte and myocyte biopsies and blood samples. The participants refrained from physical exercise and alcohol for 2 days before testing. Thus, the training sessions, clamp tests, and biopsy samplings did not interfere with each other and were performed under similar conditions at different days before as well as after the intervention.
The study was approved by the Norwegian Regional Committee for Medical and Health Research Ethics North and the Norwegian Data Inspectorate. Written consent was obtained for all participants after full explanation of the purpose and procedures used.
Insulin sensitivity
The hyperinsulinemic euglycemic clamp was performed after an overnight fast. A fixed dose of insulin 40 mU/m 2 /min 21 was infused, and glucose 200 mg/mL was adjusted to maintain plasma glucose levels at 5.0 mmol/L for 150 minutes (euglycemia) (18) . Insulin sensitivity was reported as glucose infusion rate relative to body weight (mg/kg/min) during the last 30 minutes of the clamp. Prior to the clamp, weight and fat-free mass were measured with a Tanita Body Composition Analyzer BC-418MA (Tokyo, Japan), and height was measured with a fixed stadiometer (19) . BMI was calculated from weight (kg)/ height (m) 2 .
Magnetic resonance imaging
Total adipose tissue, subcutaneous adipose tissue, and intraabdominal adipose tissue were measured by magnetic resonance imaging (MRI) scanning (1.5T Philips Achieva MR; Philips, Best, Netherlands) within 3 weeks prior to and 2 weeks after the 12-week intensive exercise intervention (17) . Examinations were performed in the evening, and no strenuous exercise was permitted the same day.
Blood
Blood glucose was measured by a glucose oxidase method (YSI 2300; YSI, Yellow Springs, OH), and plasma glucose levels were calculated (full blood glucose 3 1.119). Venous blood was centrifuged and plasma samples were kept on ice, snap-frozen in liquid nitrogen, and stored at 280°C. Plasma leptin and sOb-R levels were measured by enzyme-linked immunosorbent assay [catalog KAC2281; Invitrogen, Carlsbad, CA, and R&D Systems, Minneapolis, MN (11) , respectively].
Biopsies
Biopsies were taken at baseline and postintervention. Skeletal muscle biopsies were collected immediately before an acute exercise test from m. vastus lateralis. Subcutaneous adipose tissue biopsies were collected immediately after an acute exercise test from the periumbilical area. Biopsies from m. vastus lateralis were immediately transferred to RNA-later (Qiagen, Limburg, Netherlands), kept overnight at 4°C, and transferred to 280°C. Subcutaneous adipose biopsies were immediately frozen in liquid nitrogen and stored at 280°C until further processing.
Gene expression
Frozen biopsies from adipose tissue and skeletal muscle were powdered on ice. Gene expression was quantified by highthroughput mRNA sequencing before and after the 12-week exercise intervention performed by the Norwegian Sequencing Centre (20) . We used both a candidate gene approach and pathway analysis as described earlier (21) to study gene expression.
Pathway analysis
Pathway analysis was used to study the association between plasma sOb-R and a large number of mRNAs by correlating plasma sOb-R with the expression of genes belonging to predefined, well-studied signaling pathways. Hallmark pathways (22) , obtained from http://software.broadinstitute.org/gsea/ msigdb/, were chosen to minimize the number of tested pathways, to reduce the multiple testing problem (50 signaling pathways instead of 45,956 individual mRNAs), and to reduce the number of pathways sharing common genes. We performed overlap tests based on hypergeometric means to explore pathways associated with sOb-R and leptin levels. The number of genes significantly correlated (Spearman) with plasma levels of either leptin or sOb-R was compared with the total number of genes in a pathway using a hypergeometric distribution, which tests whether more genes in a pathway correlate with plasma leptin/sOb-R levels than expected by chance. The P values were calculated from a hypergeometric distribution in R using the syntax phyper(k-1, K, N-K, n), where K is the genes in pathway, N is the total number of genes tested, n is the total number of significantly correlated genes, and k is the significantly correlated genes in a pathway. The hypergeometric P value is calculated as the probability of randomly drawing k or more successes from the population in n total draws. To control further for multiple testing in the pathway analyses, we calculated the false discovery rate (q values). Pathway analyses were analyzed with R version 3.3.1.
Statistics
Kruskal-Wallis test was used to compare mRNA data across groups, and t tests were used to compare phenotypic data across groups. Paired t test was used to test changes in phenotypic data. Linear regression was used to test the relationship between sOb-R and insulin sensitivity. Wilcoxon test was used to test mRNA changes following the exercise intervention. Spearman rank correlation was used to test correlations between plasma sOb-R levels and mRNA of candidate genes. Stata/SE 14.2 (STATA Corp., College Station, TX) was used for statistical analyses.
Results
We studied the relationship between sOb-R, metabolism, insulin sensitivity, and gene expression in 26 sedentary men before and after a 12-week intensive exercise intervention. Baseline characteristics are presented in Table 1 .
sOb-R and metabolic phenotype
Baseline plasma levels of sOb-R correlated with baseline values of fasting glucose (r = 20.465, P = 0.017), plasma leptin (r = 20.510, P = 0.0078), and glucose infusion rate (GIR) (r = 0.531, P = 0.0052) and borderline significantly with total adipose tissue from MRI (r = 20.385, P = 0.052). sOb-R was not correlated with age (r = 0.015, P = 0.94), fasting insulin (r = 20.272, P = 0.18), fasting c-peptide (r = 20.245, P = 0.23), 2-hour plasma glucose (r = 20.18, P = 0.39), or hemoglobin A1c (r = 20.281, P = 0.16).
sOb-R and insulin sensitivity
Baseline sOb-R correlated strongly and positively with baseline GIR (Fig. 1A) . In linear regression, baseline GIR was higher by b = 1.19 mg/kg/min [95% confidence interval (CI), 0.57 to 1.82 mg/kg/min; P = 0.0006], for each ng/mL increase in sOb-R. This association was weakened but persisted after adjustment for age, group, total body fat, and plasma leptin levels (0.67; 95% CI, 0.09 to 1.24; P = 0.026). Postintervention plasma sOb-R was strongly associated with postintervention GIR (1.90; 95% CI, 1.01 to 2.79; P , 0.0001). Following the 12-week intensive exercise intervention, total body fat decreased (21.17 6 0.87 L, P , 0.0001) and plasma leptin levels decreased (22.07 6 2.44 ng/mL, P = 0.0002), whereas GIR increased (2.00 6 1.79 mg/kg/ min, P , 0.0001). sOb-R did not change following the exercise intervention (0.15 6 0.58, P = 0.20).
Thereafter, we explored the association between plasma sOb-R at baseline and the change in GIR following the 12-week exercise intervention. Higher baseline sOb-R was associated with increased improvement of GIR (0.58 mg/kg/min; 95% CI, 0.03 to 1.12 mg/kg/min) following the 12-week intensive exercise intervention (Fig. 1B) . The association between baseline sOb-R and improvement of GIR was strengthened after adjustment for covariates (Table 2) .
We explored interactions between the dysglycemic group and sOb-R, leptin, or total adipose tissue, as well as between sOb-R and leptin or total adipose tissue, but did not find any indications of interactions (P for interaction ranged from 0.35 to 0.68).
sOb-R and pathway analysis
In exploratory pathway analyses, sOb-R correlated with upregulation of Hallmark pathways associated with increased metabolism and downregulation of pathways associated with inflammation, both in adipose tissue and skeletal muscle (Table 3 and Supplemental Tables 1-3) . In adipose tissue, high plasma sOb-R levels were associated with upregulation of the Hallmark signaling pathways "oxidative phosphorylation" (false discovery rate q = 1.26 E-40), "adipogenesis" (q = 5.22E-32), "MYC targets version 1" (q = 5.56E-27), "fatty acid metabolism" (q = 1.44E-26), and "peroxisomes" (q = 6.59E-14) and downregulation of "inflammatory response" (q = 1.42E-38), "allograft rejection" (q = 7.52E-37), and "G2/M checkpoint" (q = 2.97E-30), to mention some (Table 3 and Supplemental Table 1 ). In skeletal muscle, high sOb-R levels were associated with upregulation of the Hallmark pathways "oxidative phosphorylation" (q = 6.41E-8), "MYC targets version 1" (q = 2.98E-5), "protein secretion" (q = 1.26E-3), "E2F targets" (q = 3.88E-3), and upregulation of "KRAS signaling" (q = 3.88E-3) and "mTORC1 signaling" (q = 9.7E-3) and downregulation of "P53 pathway" (q = 4.14E-7), "TNF-a signaling via NF-kb" (q = 1.56E-6), genes encoding components of the complement system (q = 4.8E-4), and "inflammatory response" (q = 2.1E-3), to mention some (Table 3 and Supplemental Table 2 ). In both adipose tissue and skeletal muscle, pathway analysis of plasma leptin showed a pattern opposite of sOb-R, with upregulation of signaling pathways associated with inflammation and Tables 4-6 ).
downregulation of metabolic pathways (Supplemental
sOb-R and mRNA of candidate genes For our candidate gene approach, in addition to LEP and LEPR, we monitored leptin receptor overlapping transcript (LEPROT) as this gene may play a role in cell surface expression of Ob-R (23) and a disintegrin and metalloproteinase domain-containing protein (ADAM) 10 and ADAM17 because these seem to be involved in shedding Ob-R (24).
In adipose tissue, baseline sOb-R was significantly correlated with LEP expression and borderline significantly correlated with ADAM17 (P = 0.055) but not with LEPR, LEPROT, LEPROTL1, or ADAM10 (Table 4) . In skeletal muscle, sOb-R correlated with mRNA of ADAM10 but not with any of the other candidate genes (Table 4) .
Following the intensive exercise intervention, in adipose tissue, expression of LEP decreased (P = 0.0079), whereas gene expression of LEPR, LEPROT, LEP-ROTL1, ADAM10, or ADAM17 did not change (Fig. 2) . In skeletal muscle, LEP and LEPR did not change, whereas LEPROT, LEPROTL1, ADAM10, and ADAM17 all increased following the intensive exercise intervention (P ranging from 0.011 to ,0.00001) (Fig. 2) , although sOb-R did not change. We found no significant correlations between change in sOb-R or change in GIR and change in the expression of any of the candidate genes (Supplemental Table 7 ).
In adipose tissue, expression of LEP and LEPR was higher in the dysglycemic group than in the controls at baseline (P = 0.0071 and P = 0.040, respectively), whereas ADAM17 was borderline significantly higher in the dysglycemic than in control group (P = 0.077) (Supplemental Fig. 1) . In skeletal muscle, we found no differences between the dysglycemic and the control group in mRNA of LEP, LEPR, LEPROT, LEPROTL1, ADAM10, or ADAM17 (P = 0.11 to 0.90) (Supplemental Fig. 1 ).
Discussion
To our knowledge, this is the first study in humans to explore how plasma sOb-R is related to insulin sensitivity measured by the glucose clamp technique and gene expression in humans. We found a strong, positive, and independent association between plasma sOb-R and insulin sensitivity. Interestingly, we also found a strong prospective correlation between plasma sOb-R at baseline Abbreviations: FDR, false discovery rate; k, number of significantly correlated genes in the pathway; K, number of genes in the pathway; k/K, proportion of genes in the pathway correlated with sOb-R; TNFA, tumor necrosis factor a. a Significant only in adipose tissue. and change in insulin sensitivity following the 12-week intensive exercise intervention. Plasma sOb-R was positively correlated with upregulation of pathways associated with increased metabolism and downregulation of pathways associated with inflammation, in both adipose tissue as well as skeletal muscle. In skeletal muscle, mRNA of LEPROT, LEPROTL1, ADAM10, and ADAM17 increased following the exercise intervention and explained parts of the association between sOb-R and change in GIR.
Our finding that sOb-R is positively correlated with insulin sensitivity is consistent with the inverse association observed between sOb-R and gestational diabetes (13) and type 2 diabetes (11) in two separate cohorts of women. Although these relationships were independent of leptin levels, these observational studies were not able to preclude residual confounding by adiposity. However, in this study, we show that sOb-R was strongly and robustly associated with insulin sensitivity also after adjustment for total body fat as measured by MRI. Hence, sOb-R seems to be a strong, independent predictor of insulin sensitivity and not simply a result of residual confounding due to its inverse association with adiposity. We did not find any studies exploring the relationship between plasma sOb-R and insulin sensitivity measured by hyperinsulinemic euglycemic clamp. However, in agreement with our finding, plasma sOb-R inversely correlated with insulin resistance measured by the homeostatic model assessment of insulin resistance in female anorectic adolescents (25) . The association between sOb-R and insulin sensitivity was also supported by the pathway analyses, which demonstrated that high sOb-R levels correlated with increased expression of metabolic pathways.
The mechanisms for the seemingly protective effect of sOb-R on insulin sensitivity and diabetes are unclear. Leptin signaling leads to increased SOCS3 expression (26) , which in turn inhibits both leptin and insulin signaling via STAT3. Experimental studies in mice have shown that deletion of SOCS3 in skeletal muscle protects obese mice from development of insulin resistance (27) , suggesting that SOCS3 might be a link between leptin resistance and insulin resistance.
sOb-R was, independently of leptin and fat mass, associated with insulin sensitivity, which is in accordance with the results from the pathway analysis that pathways associated with increased metabolism were upregulated. Moreover, we found that pathways associated with inflammatory response were downregulated, which could be due to the strong association of sOb-R with adiposity and leptin.
LEPROT has a role in cell surface expression of Ob-R (23), and ADAM10 and ADAM17 are associated with shedding of Ob-R (24) . LEPROT silencing in mice seems to improve leptin signaling in the hypothalamic arcuate nucleus, as LEPROT seems to negatively regulate Ob-R cell surface expression and thereby reduce the response to leptin (23) . Increased ADAM10 and ADAM17 activity should enhance shedding of Ob-R. Hence, the increase in LEPROT, LEPROTL1, ADAM10, and ADAM17 following exercise intervention might promote decreased leptin signaling in the muscle, which in turn may influence insulin signaling. It is possible that increased physical activity leads to altered needs of the skeletal muscle that may benefit from decreased leptin signaling to muscle cells. However, we cannot rule out that the upregulation of these genes may also reflect a general increase in turnover of LEPROT, ADAM10, and ADAM17 proteins. Importantly, there is not a direct association between mRNA and levels of functioning protein, as there may be posttranslational and other regulatory patterns. We did not find a similar increase for LEPROT, LEPROTL1, ADAM10, and ADAM17 in adipose tissue. However, the adipose tissue biopsies were taken after an acute exercise test as opposed to the skeletal muscle biopsies, which were taken immediately before the acute exercise test. Therefore, we cannot rule out that mRNAs in adipose tissue have been influenced by acute exercise.
Several animal studies suggest that sOb-R may counteract leptin signaling, but this does not seem to apply within physiologic sOb-R levels in humans. Obese individuals normally have high leptin levels and low sOb-R levels, whereas the opposite is observed in lean individuals (28) (29) (30) . Weight loss seems to be followed by increased levels of sOb-R simultaneously with reduced leptin levels (30, 31) . Although an increasing number of studies suggest that the sOb-R levels simply reflect the amount of membrane-bound leptin receptors (9, 13, 16), we did not find an association between sOb-R and LEPR expression. However, this was not unexpected considering that only 5% to 25% of the Ob-Rs (varying across the four different forms) are located at the cell membrane (32) .
Major strengths of this study are its prospective intervention design and the use of state-of-the-art methods for assessment of insulin sensitivity, total fat mass, and so on. A limitation of our study is the relatively small sample size that did not allow us to explore whether sOb-R levels may be a result of complex interactions between expressions of LEPROT, LEPROTL1, ADAM10, and ADAM17. The dysglycemic group had higher body fat and lower GIR. Hence, we cannot completely rule out potential bias, although we did not find any indications of interactions between the dysglycemic group and sOb-R, leptin, or total adipose tissue. Another limitation is that we did not include tracer-based measurements of hepatic glucose production during the clamp investigations. However, none of the participants were very insulin resistant, and we believe that the relatively high insulin doses used suppressed most of the endogenous glucose production at the end of the clamp. This study was performed in men only. However, both the previous observational studies reporting a link between sOb-R and diabetes were performed in women, whereas our study in men shows a strong relationship between sOb-R and insulin sensitivity, which is deteriorated in gestational and type 2 diabetes. Together, these studies indicate that the protective association between sOb-R and diabetes exists in both men and women.
Conclusion
sOb-R seems to be strongly correlated to insulin sensitivity cross-sectionally but also seems to predict change in insulin sensitivity following a 12-week intensive exercise intervention, independently of several covariates, including leptin. These relationships between sOb-R and insulin sensitivity may partly explain the strong protective association found in prospective observational studies between sOb-R levels and future risk of gestational and type 2 diabetes. Moreover, high sOb-R levels were related to pathways associated with increased metabolism and reduced inflammation, whereas results on expression of candidate genes for plasma sOb-R levels were inconclusive. Future studies should explore how plasma sOb-R levels are regulated and the mechanisms by which plasma sOb-R levels may improve GIR.
